Global Novel Oral Anticoagulants Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 92

Published Date: 11 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.

According to our (Global Info Research) latest study, the global Novel Oral Anticoagulants Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Americas is the largest Anticoagulant Drugs market with about 51% market share. Europe is follower, accounting for about 27% market share.The key manufacturers are Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo etc. Top 3 companies occupied about 56% market share.

This report is a detailed and comprehensive analysis for global Novel Oral Anticoagulants Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Novel Oral Anticoagulants Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Novel Oral Anticoagulants Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Novel Oral Anticoagulants Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Novel Oral Anticoagulants Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Novel Oral Anticoagulants Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Novel Oral Anticoagulants Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson and Boehringer Ingelheim and  etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Novel Oral Anticoagulants Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Direct Thrombin Inhibitor
    Factor Xa Inhibitors

Market segment by Application
    Hospital
    Drugs Stores
    Other

Major players covered
    Bristol-Myers Squibb
    Bayer
    Pfizer
    Johnson & Johnson
    Boehringer Ingelheim
    Daiichi Sankyo

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Novel Oral Anticoagulants Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Novel Oral Anticoagulants Drugs, with price, sales, revenue and global market share of Novel Oral Anticoagulants Drugs from 2018 to 2023.
Chapter 3, the Novel Oral Anticoagulants Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Novel Oral Anticoagulants Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Novel Oral Anticoagulants Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Novel Oral Anticoagulants Drugs.
Chapter 14 and 15, to describe Novel Oral Anticoagulants Drugs sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Novel Oral Anticoagulants Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Novel Oral Anticoagulants Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Direct Thrombin Inhibitor
        1.3.3 Factor Xa Inhibitors
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Novel Oral Anticoagulants Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Drugs Stores
        1.4.4 Other
    1.5 Global Novel Oral Anticoagulants Drugs Market Size & Forecast
        1.5.1 Global Novel Oral Anticoagulants Drugs Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Novel Oral Anticoagulants Drugs Sales Quantity (2018-2029)
        1.5.3 Global Novel Oral Anticoagulants Drugs Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Bristol-Myers Squibb
        2.1.1 Bristol-Myers Squibb Details
        2.1.2 Bristol-Myers Squibb Major Business
        2.1.3 Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Product and Services
        2.1.4 Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Bristol-Myers Squibb Recent Developments/Updates
    2.2 Bayer
        2.2.1 Bayer Details
        2.2.2 Bayer Major Business
        2.2.3 Bayer Novel Oral Anticoagulants Drugs Product and Services
        2.2.4 Bayer Novel Oral Anticoagulants Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Bayer Recent Developments/Updates
    2.3 Pfizer
        2.3.1 Pfizer Details
        2.3.2 Pfizer Major Business
        2.3.3 Pfizer Novel Oral Anticoagulants Drugs Product and Services
        2.3.4 Pfizer Novel Oral Anticoagulants Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Pfizer Recent Developments/Updates
    2.4 Johnson & Johnson
        2.4.1 Johnson & Johnson Details
        2.4.2 Johnson & Johnson Major Business
        2.4.3 Johnson & Johnson Novel Oral Anticoagulants Drugs Product and Services
        2.4.4 Johnson & Johnson Novel Oral Anticoagulants Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Johnson & Johnson Recent Developments/Updates
    2.5 Boehringer Ingelheim
        2.5.1 Boehringer Ingelheim Details
        2.5.2 Boehringer Ingelheim Major Business
        2.5.3 Boehringer Ingelheim Novel Oral Anticoagulants Drugs Product and Services
        2.5.4 Boehringer Ingelheim Novel Oral Anticoagulants Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Boehringer Ingelheim Recent Developments/Updates
    2.6 Daiichi Sankyo
        2.6.1 Daiichi Sankyo Details
        2.6.2 Daiichi Sankyo Major Business
        2.6.3 Daiichi Sankyo Novel Oral Anticoagulants Drugs Product and Services
        2.6.4 Daiichi Sankyo Novel Oral Anticoagulants Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Daiichi Sankyo Recent Developments/Updates

3 Competitive Environment: Novel Oral Anticoagulants Drugs by Manufacturer
    3.1 Global Novel Oral Anticoagulants Drugs Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Novel Oral Anticoagulants Drugs Revenue by Manufacturer (2018-2023)
    3.3 Global Novel Oral Anticoagulants Drugs Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Novel Oral Anticoagulants Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Novel Oral Anticoagulants Drugs Manufacturer Market Share in 2022
        3.4.2 Top 6 Novel Oral Anticoagulants Drugs Manufacturer Market Share in 2022
    3.5 Novel Oral Anticoagulants Drugs Market: Overall Company Footprint Analysis
        3.5.1 Novel Oral Anticoagulants Drugs Market: Region Footprint
        3.5.2 Novel Oral Anticoagulants Drugs Market: Company Product Type Footprint
        3.5.3 Novel Oral Anticoagulants Drugs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Novel Oral Anticoagulants Drugs Market Size by Region
        4.1.1 Global Novel Oral Anticoagulants Drugs Sales Quantity by Region (2018-2029)
        4.1.2 Global Novel Oral Anticoagulants Drugs Consumption Value by Region (2018-2029)
        4.1.3 Global Novel Oral Anticoagulants Drugs Average Price by Region (2018-2029)
    4.2 North America Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)
    4.3 Europe Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)
    4.4 Asia-Pacific Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)
    4.5 South America Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)
    4.6 Middle East and Africa Novel Oral Anticoagulants Drugs Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2029)
    5.2 Global Novel Oral Anticoagulants Drugs Consumption Value by Type (2018-2029)
    5.3 Global Novel Oral Anticoagulants Drugs Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2029)
    6.2 Global Novel Oral Anticoagulants Drugs Consumption Value by Application (2018-2029)
    6.3 Global Novel Oral Anticoagulants Drugs Average Price by Application (2018-2029)

7 North America
    7.1 North America Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2029)
    7.2 North America Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2029)
    7.3 North America Novel Oral Anticoagulants Drugs Market Size by Country
        7.3.1 North America Novel Oral Anticoagulants Drugs Sales Quantity by Country (2018-2029)
        7.3.2 North America Novel Oral Anticoagulants Drugs Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2029)
    8.2 Europe Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2029)
    8.3 Europe Novel Oral Anticoagulants Drugs Market Size by Country
        8.3.1 Europe Novel Oral Anticoagulants Drugs Sales Quantity by Country (2018-2029)
        8.3.2 Europe Novel Oral Anticoagulants Drugs Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Novel Oral Anticoagulants Drugs Market Size by Region
        9.3.1 Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Novel Oral Anticoagulants Drugs Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2029)
    10.2 South America Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2029)
    10.3 South America Novel Oral Anticoagulants Drugs Market Size by Country
        10.3.1 South America Novel Oral Anticoagulants Drugs Sales Quantity by Country (2018-2029)
        10.3.2 South America Novel Oral Anticoagulants Drugs Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Novel Oral Anticoagulants Drugs Market Size by Country
        11.3.1 Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Novel Oral Anticoagulants Drugs Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Novel Oral Anticoagulants Drugs Market Drivers
    12.2 Novel Oral Anticoagulants Drugs Market Restraints
    12.3 Novel Oral Anticoagulants Drugs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Novel Oral Anticoagulants Drugs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Novel Oral Anticoagulants Drugs
    13.3 Novel Oral Anticoagulants Drugs Production Process
    13.4 Novel Oral Anticoagulants Drugs Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Novel Oral Anticoagulants Drugs Typical Distributors
    14.3 Novel Oral Anticoagulants Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Novel Oral Anticoagulants Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Novel Oral Anticoagulants Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 4. Bristol-Myers Squibb Major Business
    Table 5. Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Product and Services
    Table 6. Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Bristol-Myers Squibb Recent Developments/Updates
    Table 8. Bayer Basic Information, Manufacturing Base and Competitors
    Table 9. Bayer Major Business
    Table 10. Bayer Novel Oral Anticoagulants Drugs Product and Services
    Table 11. Bayer Novel Oral Anticoagulants Drugs Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Bayer Recent Developments/Updates
    Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 14. Pfizer Major Business
    Table 15. Pfizer Novel Oral Anticoagulants Drugs Product and Services
    Table 16. Pfizer Novel Oral Anticoagulants Drugs Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Pfizer Recent Developments/Updates
    Table 18. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 19. Johnson & Johnson Major Business
    Table 20. Johnson & Johnson Novel Oral Anticoagulants Drugs Product and Services
    Table 21. Johnson & Johnson Novel Oral Anticoagulants Drugs Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Johnson & Johnson Recent Developments/Updates
    Table 23. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 24. Boehringer Ingelheim Major Business
    Table 25. Boehringer Ingelheim Novel Oral Anticoagulants Drugs Product and Services
    Table 26. Boehringer Ingelheim Novel Oral Anticoagulants Drugs Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Boehringer Ingelheim Recent Developments/Updates
    Table 28. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
    Table 29. Daiichi Sankyo Major Business
    Table 30. Daiichi Sankyo Novel Oral Anticoagulants Drugs Product and Services
    Table 31. Daiichi Sankyo Novel Oral Anticoagulants Drugs Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Daiichi Sankyo Recent Developments/Updates
    Table 33. Global Novel Oral Anticoagulants Drugs Sales Quantity by Manufacturer (2018-2023) & (K MT)
    Table 34. Global Novel Oral Anticoagulants Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 35. Global Novel Oral Anticoagulants Drugs Average Price by Manufacturer (2018-2023) & (USD/MT)
    Table 36. Market Position of Manufacturers in Novel Oral Anticoagulants Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 37. Head Office and Novel Oral Anticoagulants Drugs Production Site of Key Manufacturer
    Table 38. Novel Oral Anticoagulants Drugs Market: Company Product Type Footprint
    Table 39. Novel Oral Anticoagulants Drugs Market: Company Product Application Footprint
    Table 40. Novel Oral Anticoagulants Drugs New Market Entrants and Barriers to Market Entry
    Table 41. Novel Oral Anticoagulants Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 42. Global Novel Oral Anticoagulants Drugs Sales Quantity by Region (2018-2023) & (K MT)
    Table 43. Global Novel Oral Anticoagulants Drugs Sales Quantity by Region (2024-2029) & (K MT)
    Table 44. Global Novel Oral Anticoagulants Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 45. Global Novel Oral Anticoagulants Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 46. Global Novel Oral Anticoagulants Drugs Average Price by Region (2018-2023) & (USD/MT)
    Table 47. Global Novel Oral Anticoagulants Drugs Average Price by Region (2024-2029) & (USD/MT)
    Table 48. Global Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2023) & (K MT)
    Table 49. Global Novel Oral Anticoagulants Drugs Sales Quantity by Type (2024-2029) & (K MT)
    Table 50. Global Novel Oral Anticoagulants Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 51. Global Novel Oral Anticoagulants Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 52. Global Novel Oral Anticoagulants Drugs Average Price by Type (2018-2023) & (USD/MT)
    Table 53. Global Novel Oral Anticoagulants Drugs Average Price by Type (2024-2029) & (USD/MT)
    Table 54. Global Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2023) & (K MT)
    Table 55. Global Novel Oral Anticoagulants Drugs Sales Quantity by Application (2024-2029) & (K MT)
    Table 56. Global Novel Oral Anticoagulants Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 57. Global Novel Oral Anticoagulants Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 58. Global Novel Oral Anticoagulants Drugs Average Price by Application (2018-2023) & (USD/MT)
    Table 59. Global Novel Oral Anticoagulants Drugs Average Price by Application (2024-2029) & (USD/MT)
    Table 60. North America Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2023) & (K MT)
    Table 61. North America Novel Oral Anticoagulants Drugs Sales Quantity by Type (2024-2029) & (K MT)
    Table 62. North America Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2023) & (K MT)
    Table 63. North America Novel Oral Anticoagulants Drugs Sales Quantity by Application (2024-2029) & (K MT)
    Table 64. North America Novel Oral Anticoagulants Drugs Sales Quantity by Country (2018-2023) & (K MT)
    Table 65. North America Novel Oral Anticoagulants Drugs Sales Quantity by Country (2024-2029) & (K MT)
    Table 66. North America Novel Oral Anticoagulants Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 67. North America Novel Oral Anticoagulants Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 68. Europe Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2023) & (K MT)
    Table 69. Europe Novel Oral Anticoagulants Drugs Sales Quantity by Type (2024-2029) & (K MT)
    Table 70. Europe Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2023) & (K MT)
    Table 71. Europe Novel Oral Anticoagulants Drugs Sales Quantity by Application (2024-2029) & (K MT)
    Table 72. Europe Novel Oral Anticoagulants Drugs Sales Quantity by Country (2018-2023) & (K MT)
    Table 73. Europe Novel Oral Anticoagulants Drugs Sales Quantity by Country (2024-2029) & (K MT)
    Table 74. Europe Novel Oral Anticoagulants Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 75. Europe Novel Oral Anticoagulants Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 76. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2023) & (K MT)
    Table 77. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity by Type (2024-2029) & (K MT)
    Table 78. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2023) & (K MT)
    Table 79. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity by Application (2024-2029) & (K MT)
    Table 80. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity by Region (2018-2023) & (K MT)
    Table 81. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity by Region (2024-2029) & (K MT)
    Table 82. Asia-Pacific Novel Oral Anticoagulants Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 83. Asia-Pacific Novel Oral Anticoagulants Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 84. South America Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2023) & (K MT)
    Table 85. South America Novel Oral Anticoagulants Drugs Sales Quantity by Type (2024-2029) & (K MT)
    Table 86. South America Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2023) & (K MT)
    Table 87. South America Novel Oral Anticoagulants Drugs Sales Quantity by Application (2024-2029) & (K MT)
    Table 88. South America Novel Oral Anticoagulants Drugs Sales Quantity by Country (2018-2023) & (K MT)
    Table 89. South America Novel Oral Anticoagulants Drugs Sales Quantity by Country (2024-2029) & (K MT)
    Table 90. South America Novel Oral Anticoagulants Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 91. South America Novel Oral Anticoagulants Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 92. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity by Type (2018-2023) & (K MT)
    Table 93. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity by Type (2024-2029) & (K MT)
    Table 94. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity by Application (2018-2023) & (K MT)
    Table 95. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity by Application (2024-2029) & (K MT)
    Table 96. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity by Region (2018-2023) & (K MT)
    Table 97. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity by Region (2024-2029) & (K MT)
    Table 98. Middle East & Africa Novel Oral Anticoagulants Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 99. Middle East & Africa Novel Oral Anticoagulants Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 100. Novel Oral Anticoagulants Drugs Raw Material
    Table 101. Key Manufacturers of Novel Oral Anticoagulants Drugs Raw Materials
    Table 102. Novel Oral Anticoagulants Drugs Typical Distributors
    Table 103. Novel Oral Anticoagulants Drugs Typical Customers
List of Figures
    Figure 1. Novel Oral Anticoagulants Drugs Picture
    Figure 2. Global Novel Oral Anticoagulants Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Novel Oral Anticoagulants Drugs Consumption Value Market Share by Type in 2022
    Figure 4. Direct Thrombin Inhibitor Examples
    Figure 5. Factor Xa Inhibitors Examples
    Figure 6. Global Novel Oral Anticoagulants Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Novel Oral Anticoagulants Drugs Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Examples
    Figure 9. Drugs Stores Examples
    Figure 10. Other Examples
    Figure 11. Global Novel Oral Anticoagulants Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Novel Oral Anticoagulants Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Novel Oral Anticoagulants Drugs Sales Quantity (2018-2029) & (K MT)
    Figure 14. Global Novel Oral Anticoagulants Drugs Average Price (2018-2029) & (USD/MT)
    Figure 15. Global Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Novel Oral Anticoagulants Drugs Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Novel Oral Anticoagulants Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Novel Oral Anticoagulants Drugs Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Novel Oral Anticoagulants Drugs Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Novel Oral Anticoagulants Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Novel Oral Anticoagulants Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Novel Oral Anticoagulants Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Novel Oral Anticoagulants Drugs Average Price by Type (2018-2029) & (USD/MT)
    Figure 30. Global Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Novel Oral Anticoagulants Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Novel Oral Anticoagulants Drugs Average Price by Application (2018-2029) & (USD/MT)
    Figure 33. North America Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Novel Oral Anticoagulants Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Novel Oral Anticoagulants Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Novel Oral Anticoagulants Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Novel Oral Anticoagulants Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Novel Oral Anticoagulants Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Novel Oral Anticoagulants Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Novel Oral Anticoagulants Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Novel Oral Anticoagulants Drugs Market Drivers
    Figure 74. Novel Oral Anticoagulants Drugs Market Restraints
    Figure 75. Novel Oral Anticoagulants Drugs Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Novel Oral Anticoagulants Drugs in 2022
    Figure 78. Manufacturing Process Analysis of Novel Oral Anticoagulants Drugs
    Figure 79. Novel Oral Anticoagulants Drugs Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Boehringer Ingelheim
Daiichi Sankyo

Related Reports

Global Novel Oral Anticoagulants Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Novel Oral Anticoagulants Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 12 Feb 2021

date Pharma & Healthcare

The Novel Oral Anticoagulants Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Novel Oral Anticoagulants Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Novel Oral Anticoagulants Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 16 Jan 2022

date Pharma & Healthcare

Global Novel Oral Anticoagulants Drugs Supply, Demand and Key Producers, 2023-2029

Global Novel Oral Anticoagulants Drugs Supply, Demand and Key Producers, 2023-2029

date 09 Aug 2023

date Medical Care

The global Novel Oral Anticoagulants Drugs market size is expected to reach $ 42300 million by 2029, rising at a market growth of 9.8% CAGR during the forecast period (2023-2029).

Global Novel Oral Anticoagulants Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Novel Oral Anticoagulants Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 09 Aug 2023

date Medical Care

According to our (Global Info Research) latest study, the global Novel Oral Anticoagulants Drugs market size was valued at USD 22040 million in 2022 and is forecast to a readjusted size of USD 42300 million by 2029 with a CAGR of 9.8% during review period.

Global Novel Oral Anticoagulants Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Novel Oral Anticoagulants Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Novel Oral Anticoagulants Drugs market size was valued at USD 22040 million in 2023 and is forecast to a readjusted size of USD 42300 million by 2030 with a CAGR of 9.8% during review period.

Product Tags

novel oral anticoagulants drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>